Interleukin-1β elevation during the postpartum period

Annals of Behavioral Medicine

Volumn 25, Issue 1, 2003, Pages 41-47

  Corwin, Elizabeth J ^a   Bozoky, Ingrid ^b   Pugh, Linda C ^b   Johnston, Nancy ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FEMALE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MENTAL DISEASE; PUERPERAL DEPRESSION; SYMPTOMATOLOGY; URINARY EXCRETION; BREAST FEEDING; PATHOPHYSIOLOGY; PREGNANCY; PUERPERIUM; URINE;

ADULT; BREAST FEEDING; FATIGUE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; POSTPARTUM PERIOD; PREGNANCY;

EID: 0037266211     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15324796ABM2501_06     Document Type: Article

References (67)

1. Auerbach KG: Employed breastfeeding mothers: Problems they encounter. Birth. 1984, 11:17-20.
2. Chapman JJ, Macey MJ, Keegan M, Borum P, Bennett S: Concerns of breast-feeding mothers from birth to 4 months. Nursing Research. 1985, 34:374-377.
3. Gardner DL: Fatigue in postpartum women. Applied Nursing Research. 1991, 4:57-62.
4. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern PM: Changes in women's physical health during the first postpartum year. Archives of Family Medicine. 1993, 2:277-283.
5. Gruis M: Beyond maternity: Postpartum concerns of mothers. MCN, American Journal of Maternal Child Nursing. 1977, 2:182-188.
6. Milligan RA: Maternal fatigue during the first three months of the postpartum period. Dissertation Abstracts International. 1989, 50:07-B.
7. Milligan RA, Pugh LC: Fatigue during the childbearing period. Annual Review of Nursing Research. 1994, 12:33-49.
8. Parks PL, Lenz ER, Han H, Milligan RA: What happens when fatigue lingers for 18 months after delivery? Journal of Obstetric, Gynecologic, and Neonatal Nursing. 1999, 28:87-93.
9. Affonso DD, Lovett S, Paul SM, Sheptak S: A standardized interview that differentiates pregnancy and postpartum symptoms from perinatal clinical depression. Birth. 1990, 17:121-130.
10. Caltabiano NJ, Caltabiano ML: Relationship between exhaustion and postnatal depression. Psychological Reports. 1996, 79:225-226.
11. Troy NW: A comparison of fatigue and energy levels at 6 weeks and 14 to 19 months postpartum. Clinical Nursing Research. 1999, 8:135-152.
12. Lee KA, Zaffke ME: Longitudinal changes in fatigue and energy during the pregnancy and the postpartum period. Journal of Obstetric, Gynecologic, and Neonatal Nursing. 1999, 28:183-191.
13. Forster C, Abraham S, Taylor A, Llewellyn-Jones D: Psychological and sexual changes after the cessation of breast-feeding. Obstetrics & Gynecology. 1994, 84:872-876.
14. Blade J, Kyle RA, Greipp PR: Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. British Journal of Haematology. 1996, 93:345-351.
15. Ford H, Trigwell P, Johnson M: The nature of fatigue in multiple sclerosis. Journal of Psychosomatic Research. 1998, 45:33-38.
16. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine. 1999, 340:448-454.
17. Glaus A, Crow R, Hammond S: A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Supportive Care in Cancer. 1996, 4:82-96.
18. Rose L, Pugh LC, Lears K, Gordon DL: The fatigue experience: Persons with HIV infection. Journal of Advanced Nursing. 1998, 28:295-304.
19. Winningham ML, Nail LM, Burke MB, et al.: Fatigue and the cancer experience: The state of the knowledge. Oncology Nursing Forum. 1994, 21:23-36.
20. Cannon JG, Evans WJ, Hughes VA, Meredith CN, Dinarello CA: Physiological mechanisms contributing to increased interleukin-1 secretion. Journal of Applied Physiology. 1986, 61:1869-1874.
21. Corwin EJ: Understanding cytokines Part I: Physiology & mechanisms of action. Biological Research for Nursing. 2000, 2:30-40.
22. Dinarello CA: Cytokines as endogenous pyrogens. Journal of Infectious Diseases. 1999, 179:S294-304
23. Krueger JM, Toth LA, Floyd R, et al.: Sleep, microbes, and cytokines. Neuroimmunomodulation. 1994, 1:100-109.
24. Watkins LR, Nguyen KT, Lee JE, Maier SF: Dynamic regulation of proinflammatory cytokines. Advances in Experimental Medicine and Biology. 1999, 461:153-178.
25. Dinarello CA: An update on human interleukin-1: From molecular biology to clinical relevance. Journal of Clinical Immunology. 1985, 5:287-297.
26. Dinarello CA, Cannon JG, Mier JW, et al.: Multiple biological activities of human recombinant interleukin 1. Journal of Clinical Investigation. 1986, 77:1734-1739.
27. Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L: Sleep-promoting effects of endogenous pyrogen (interleukin-1). American Journal of Physiology. 1984, 246:R994-R999.
28. Anisman H, Merali Z: Anhedonic and anxiogenic effects of cytokine exposure. Advances in Experimental Medicine and Biology. 1999, 461:199-234.
29. Dinarello CA: Interleukin-1. In Thomson A (ed), The Cytokine Handbook (3rd Ed.). San Diego, CA: Academic, 1998, 35-72.
30. Kent S, Bluthe RM, Kelley KW, Dantzer R: Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences. 1992, 20:171-175.
31. Lau AS: Cytokines in the pathogenesis and treatment of infectious diseases. Advances in Pediatric Infectious Diseases. 1994, 9:211-236.
32. Maes M: Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology. 1999, 461:25-46.
33. Crown J, Jakubowski A, Kemeny N, et al.: A phase 1 trial of recombinant human interleukin-1B alone & in combination with myelosuppressive doses of 5-fluoruracil in patients with gastro-intestional cancer. Blood. 1991, 78:1420-1427.
34. Nemunaitis J, Appelbaum FR, Lilleby K, et al.: Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood. 1994, 83:3473-3479.
35. Smith JW, Urba WJ, Curti BD, et al.: The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. Journal of Clinical Oncology. 1992, 10:1141-1152.
36. Arntzen KJ, Lien E, Austgulen R: Maternal serum levels of IL-6 and clinical characteristics of normal delivery at term. Acta Obstetricia et Gynecologica Scandinavica. 1997, 76:55-60.
37. De Jongh RF, Bosmans EP, Puylaert MJ, et al.: The influence of anaesthetic techniques and type of delivery on peripartum serum interleukin-6 concentrations. Acta Anaesthesiologica Scandinavica. 1997, 41:853-860.
38. Tranchot-Diallo J, Gras G, Parnet-Mathieu F, et al.: Modulations of cytokine expression in pregnant women. American Journal of Reproductive Immunology. 1997, 37:215-226.
39. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I: Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators of Inflammation. 1998, 7:69-72.
40. Bessler H, Straussberg R, Hart J, Notti I, Sirota L: Human colostrum stimulates cytokine production. Biology of the Neonate. 1996, 69:376-382.
41. Bocci V, von Bremen K, Corradeschi F, et al.: Presence of interferon-gamma and interleukin-6 in colostrum of normal women. Lymphokine & Cytokine Research. 1993, 12:21-24.
42. Goldman AS, Chheda S, Garafalo R, Schmalsteig FC: Cytokines in human milk: Properties and potential effects upon mammary gland and the neonate. Mammary Gland Biologia Neoplasia. 1996, 1:251-258.
43. Hawkes JS, Bryan DL, James MJ, Gibson RA: Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatric Research. 1999, 46:194-199.
44. Munoz C, Endres S, van der Meer J, et al.: Interleukin-1 beta in human colostrum. Research in Immunology. 1990, 141:505-513.
45. Srivastava MD, Srivastava A, Brouhard B, et al.: Cytokines in human milk. Research Communications in Molecular Pathology & Pharmacology. 1996, 93:263-287.
46. Abraham S, Child A, Ferry J, Vizzard J, Mira M: Recovery after childbirth: a preliminary prospective study. Medical Journal of Australia. 1990, 152:9-12.
47. Connolly AM, Thorp JM: Childbirth-related perineal trauma: Clinical significance and prevention. Clinical Obstetrics and Gynecology. 1999, 42:820-835.
48. Sampselle CM, Hines S: Spontaneous pushing during birth. Relationship to perineal outcomes. Journal Nurse-Midwifery. 1999, 44:36-39.
49. Hill PD, Humenick SS: The occurrence of breast engorgement. Journal of Human Lactation. 1994, 10:79-86.
50. Wong S, Stepp-Gilbert E: Lactation suppression. Nonpharmaceutical versus pharmaceutical method. Journal Obstetric, Gynecologic, Neonatal Nursing. 1985, 14:302-310.
51. Yoshitake H: Three characteristic patterns of subjective fatigue symptoms. Ergonomics. 1978, 21:231-233.
52. Pugh LC, Milligan RA, Parks P, Lenz E, Kitzman H: Clinical approaches to the assessment of maternal fatigue. Journal of Obstetric, Gynecologic, and Neonatal Nursing. 1999, 28:74-80.
53. Radloff LS: The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977, 1:385-401.
54. Spielberger CD: State-Trait Anxiety Inventory: A Comprehensive Bibliography. Palo Alto, CA: Consulting Psychologists Press, 1983.
55. Pugh LC, Buchko BL, Bishop BA, et al.: A comparison of topical agents to relieve nipple pain and enhance breastfeeding. Birth. 1996, 23:88-93.
56. Lynch EA, Dinarello CA, Cannon JG: Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. Journal of Immunology. 1994, 153:300-306.
57. Ramsey KH, Schneider H, Cross AS, et al.: Inflammatory cytokines produced in response to experimental human gonorrhea. Journal of Infectious Diseases. 1995, 172:186-191.
58. Corwin EJ, Cannon JG: Gonadotropin modulation of interleukin-1 secretion. Journal of Gender Specific Medicine. 1999, 2:30-34.
59. Gormley SMC, McBride WT, Armstrong MA, et al.: Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology. 2000, 93:1210-1216.
60. Sprenger H, Jacobs C, Nain M, et al.: Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clinical Immunology and Immunopathology. 1992, 63:188-195.
61. Aaronson LS, Teel CS, Cassmeyer V, et al.: Defining and measuring fatigue. Image: Journal of Nursing Scholarship. 1999, 31:45-50.
62. Pike JL, Smith TL, Hauger RL, et al.: Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosomatic Medicine. 1997, 59:447-457.
63. Beck CT: The effects of postpartum depression on maternal-infant interaction: A meta-analysis. Nursing Research. 1995, 44:298-304.
64. Maes M: Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology. 1999, 461:25-46.
65. Watkins LR, Nguyen KT, Lee JE, Maier SF: Dynamic regulation of proinflammatory cytokines. Advances in Experimental Medicine and Biology. 1999, 461:153-178.
66. Maes M, Lin AH, Ombelet W, et al.: Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology. 2000, 25:121-137.
67. Dantzer R, Aubert A, Bluthe RM, et al.: Mechanisms of the behavioural effects of cytokines. Advances in Experimental Medicine and Biology. 1999, 461:83-105.